You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/75774
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKichuk, Stephen A.-
dc.contributor.authorTorres, Albina Rodrigues-
dc.contributor.authorFontenelle, Leonardo F.-
dc.contributor.authorRosário, Maria Conceição-
dc.contributor.authorShavitt, Roseli G.-
dc.contributor.authorMiguel, Eurípedes C.-
dc.contributor.authorPittenger, Christopher-
dc.contributor.authorBloch, Michael H.-
dc.date.accessioned2014-05-27T11:29:49Z-
dc.date.accessioned2016-10-25T18:50:20Z-
dc.date.available2014-05-27T11:29:49Z-
dc.date.available2016-10-25T18:50:20Z-
dc.date.issued2013-07-01-
dc.identifierhttp://dx.doi.org/10.1016/j.pnpbp.2013.02.003-
dc.identifier.citationProgress in Neuro-Psychopharmacology and Biological Psychiatry, v. 44, p. 233-239.-
dc.identifier.issn0278-5846-
dc.identifier.issn1878-4216-
dc.identifier.urihttp://hdl.handle.net/11449/75774-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/75774-
dc.description.abstractMeta-analysis of the heterogeneous symptoms of obsessive-compulsive disorder (OCD) has found a four-factor structure of symptom dimensions consisting of cleaning, forbidden thoughts, symmetry, and hoarding. Research into age of onset of symptom dimensions has yielded inconsistent results, and it is unknown whether symptoms along these dimensions differ in their clinical course. We assessed age of onset and clinical course of different OCD symptom dimensions in a large cohort of adult patients. Nine-hundred fifty-five subjects were assessed using the Dimensional Yale-Brown Obsessive-Compulsive Scale. For age of onset analysis, we tested across three methods of classification: (1) primary (more severe) symptom dimension (2) clinically significant symptoms within a dimension or (3) any symptoms within a dimension. Age of onset was defined as the earliest age of onset reported for any individual item within a symptom dimension. For analysis of different types of clinical course, we used chi-square tests to assess for differences between primary symptom dimensions. OCD symptoms in the symmetry dimension had an earlier age of onset than other OCD symptom dimensions. These findings remained significant across all three methods of classification and controlling for gender and comorbid tics. No significant differences were found between the other dimensions. Subjects with primary OCD symptoms in the forbidden thoughts dimension were more likely to report a waxing-and-waning course, whereas symmetry symptoms were less likely to be associated with a waxing-and-waning course. © 2013.en
dc.format.extent233-239-
dc.language.isoeng-
dc.sourceScopus-
dc.subjectadult-
dc.subjectclinical feature-
dc.subjectcomorbidity-
dc.subjectdisease association-
dc.subjectdisease classification-
dc.subjectdisease severity-
dc.subjectfemale-
dc.subjectgeneral condition deterioration-
dc.subjecthuman-
dc.subjectmajor clinical study-
dc.subjectmale-
dc.subjectobsessive compulsive disorder-
dc.subjectobsessive hoarding-
dc.subjectonset age-
dc.subjectpsychologic assessment-
dc.subjectsex difference-
dc.subjectsymptom assessment-
dc.subjectsymptomatology-
dc.subjectthought disorder-
dc.subjecttic-
dc.subjectYale Brown Obsessive Compulsive Scale-
dc.titleSymptom dimensions are associated with age of onset and clinical course of obsessive-compulsive disorderen
dc.typeoutro-
dc.contributor.institutionYale University-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionFederal University of Rio de Janeiro-
dc.contributor.institutionUniversidade de São Paulo (USP)-
dc.description.affiliationDepartment of Psychiatry Yale University-
dc.description.affiliationDepartment of Neurology, Psychology and Psychiatry Botucatu Medical School Univ Estadual Paulista, Botucatu (SP)-
dc.description.affiliationAnxiety and Depression Research Program Institute of Psychiatry Federal University of Rio de Janeiro, Rio de Janeiro (RJ)-
dc.description.affiliationDepartment of Psychiatry Federal University of São Paulo Medical School, São Paulo (SP)-
dc.description.affiliationDepartment of Psychiatry University of São Paulo Medical School, São Paulo (SP)-
dc.description.affiliationDepartment of Psychology Yale University-
dc.description.affiliationChild Study Center Yale University-
dc.description.affiliationUnespDepartment of Neurology, Psychology and Psychiatry Botucatu Medical School Univ Estadual Paulista, Botucatu (SP)-
dc.identifier.doi10.1016/j.pnpbp.2013.02.003-
dc.identifier.wosWOS:000320297400031-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofProgress in Neuro-Psychopharmacology and Biological Psychiatry-
dc.identifier.scopus2-s2.0-84876323992-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.